NANOCLAMP AF
The primary objective of this Pivotal study is to demonstrate the safety and effectiveness of the Pulse Biosciences nsPFA™ Cardiac Surgery System in treating atrial fibrillation during concomitant cardiac surgical procedures.
- Investigator
- Thomas M Beaver
- Status
- Accepting Candidates
- Ages
- 18 Years - 85 Years
- Sexes
- All
ARISE III
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
- Investigator
- Thomas M Beaver
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
ARISE II
The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the ascending aorta and aortic arch.
- Investigator
- Thomas M Beaver
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All